Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:18:55 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Q:ENGN - ENGENE HOLDINGS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ENGN - Q0.23.62·3.850.23.79+0.113.044.11473143.72  3.80  3.7011.00  2.6617:30:55Jul 0815 min RT 2¢

Recent Trades - Last 10 of 314
Time ETExPriceChangeVolume
17:30:55Q3.79990.11992
17:29:38Q3.790.11120
17:26:04Q3.67-0.01200
16:04:12Q3.790.111
16:04:11Q3.790.111
16:00:01Q3.790.11798
16:00:01Q3.790.11100
16:00:01Q3.790.1124
16:00:01Q3.790.1121
16:00:01Q3.790.114

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-08 08:00U:ENGNNews ReleaseenGene Announces Board and Leadership Appointments to Support Commercial Readiness
2025-06-25 08:00U:ENGNNews ReleaseFDA Grants RMAT Designation for enGene's Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer
2025-06-17 08:00U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-06-12 08:00U:ENGNNews ReleaseenGene Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-06-04 08:30U:ENGNNews ReleaseenGene Announces the Resignation of its Chief Medical Officer
2025-05-29 08:00U:ENGNNews ReleaseenGene to Present at the Jefferies Global Healthcare Conference
2025-05-28 07:30U:ENGNNews ReleaseenGene Names Amy Pott as Chief Global Commercialization Officer
2025-04-28 08:00U:ENGNNews ReleaseenGene to Participate in Upcoming Investor Conferences
2025-04-04 08:00U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-04-01 08:00U:ENGNNews ReleaseenGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum
2025-03-10 16:05U:ENGNNews ReleaseenGene Reports First Quarter 2025 Financial Results and Provides Business Update
2025-03-04 08:00U:ENGNNews ReleaseenGene to Participate in the Leerink Partners Global Healthcare Conference
2025-02-04 08:00U:ENGNNews ReleaseenGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
2025-01-31 16:05U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-01-30 08:00U:ENGNNews ReleaseenGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC)
2024-12-30 16:05U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2024-12-19 16:05U:ENGNNews ReleaseenGene Reports Full Year 2024 Financial Results and Provides a Business Update
2024-11-25 08:00U:ENGNNews ReleaseenGene to Participate in Upcoming Investor Conferences
2024-11-05 08:00U:ENGNNews ReleaseenGene to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
2024-10-25 08:00U:ENGNNews ReleaseenGene Announces $60 Million Private Placement Financing